Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

This study has been completed.
Sponsor:
Information provided by:
Kyowa Kirin Pharmaceutical Development, Inc.
ClinicalTrials.gov Identifier:
NCT00456794
First received: April 3, 2007
Last updated: July 13, 2016
Last verified: July 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2003
  Primary Completion Date: October 2003 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):